GeneDx Holdings Corp. (WGS) stock
WGSNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/3058% above fair value
$47.29−3.73 (-7.31%)
Close on Nov 17, 2026Market cap $1.41BP/E –Yield –
GeneDx market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
GeneDx's market cap was $1.63B on Nov 10, 2026, against $4.82B a year earlier. Over the last 5 years it ranged from $1.46K to $4.82B, with a median of $846.84M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 10, 2026 | $1.63B | -56.5% |
| 2025 | Dec 31, 2025 | $3.76B | +78.2% |
| 2024 | Dec 31, 2024 | $2.11B | +2863.2% |
| 2023 | Dec 29, 2023 | $71.16M | -28.2% |
| 2022 | Dec 30, 2022 | $99.17M | +6006654.6% |
| 2021 | Jan 29, 2021 | $1.65K | +13.3% |
| 2020 | Dec 31, 2020 | $1.46K | – |
See a number that looks wrong?